BioSpace News Archive

Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on rare and degenerative diseases, today announced the appointment of June Bray, a pharmaceutical industry veteran and global drug development and regulatory process expert, to the company’s Board of Directors.

Asher Biotherapeutics, Inc. (Asher Bio) , a biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious diseases, today announced the appointment of Andrea Pirzkall, M.D., as its first Chief Medical Officer.

ATCC to collaborate with Gennova Biopharmaceuticals, the U.S. Food and Drug Administration, Ohio State University, and McGill University on a Leishmania donovani diagnostic test and Leishmania major vaccine.

Guardant Health, Inc. announced it has purchased the remaining shares of Guardant Health AMEA, Inc., held by SoftBank and its affiliates, giving the company full control over operations throughout the Asia, Middle East and Africa region.

Soleno Therapeutics, Inc. (Soleno or the Company) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today presented new positive clinical data from its ongoing late-stage DCCR development program for the treatment of Prader-Willi syndrome (PWS) at ENDO 2022, which is being held June 11-14, 2022, in Atlanta, Georgia, USA.

Treadwell Therapeutics announced the initiation of patient dosing in TWT-203, its Phase 1b/2 study to evaluate CFI-402257, an oral, best-in-class inhibitor of Threonine Tyrosine Kinase in patients with advanced solid tumors and ER+/Her2- breast cancer.

Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the appointment of Keith A. Goldan to the role of Chief Financial Officer, effective immediately.

Lumicell, Inc ., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced it is building a commercial team to prepare for market launch of the Lumicell Direct Visualization System (DVS), which includes its novel optical imaging agent LUMISIGHT.

Spectral Medical Inc. today announced that ARC Dialysis, the largest inpatient dialysis provider in South Florida, has selected the SAMI device for inpatient dialysis services.

Orpyx® Medical Technologies Inc. (Orpyx), a digital health company focused on extending the health span of patients with diabetes, announced the launch of the Orpyx SI® Flex Sensory Insole system and Orpyx Remote Patient Monitoring (RPM) services.